Literature DB >> 18850265

Gender differences in the prevalence and behavioral risk factors of HIV in South African drug users.

Sarra L Hedden1, Damiya Whitaker, Leah Floyd, William W Latimer.   

Abstract

South Africa continues to be the global epicenter of HIV infection. Further, extensive gender disparities in HIV infection exist with females four times as likely to be infected with HIV/AIDS as males (UNAIDS, AIDS epidemic update, 2006; WHO, Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections, 2006). A cross-sectional collection of drug users recruited in the Pretoria region of South Africa (N = 385) was used to model HIV infection as a function of sexual risk behaviors and drug use as modified by gender. Receiving money from illicit sources and knowing someone with AIDS were loosely associated with HIV. Gender interactions were observed for age, cocaine use and condom use. Gender stratified analyses revealed that males who used condoms, were younger and tested negative for cocaine use were less likely to test positive for HIV. Findings suggest that males may have more control of risk behaviors and support the need for gender specific prevention strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18850265      PMCID: PMC6414056          DOI: 10.1007/s10461-008-9467-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  9 in total

1.  Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa.

Authors:  Janan J Dietrich; Erica Lazarus; Michele Andrasik; Stefanie Hornschuh; Kennedy Otwombe; Cecilia Morgan; Abby J Isaacs; Yunda Huang; Fatima Laher; James G Kublin; Glenda E Gray
Journal:  AIDS Behav       Date:  2018-07

2.  Alcohol, Drug and Sexual Risk Behavior Correlates of Recent Transactional Sex Among Female Black South African Drug Users.

Authors:  Sarra L Hedden; Alicia Hulbert; Courtenay E Cavanaugh; Charles D Parry; Anne Gloria Moleko; William W Latimer
Journal:  J Subst Use       Date:  2011-02

Review 3.  people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa.

Authors:  Alice K Asher; Judith A Hahn; Marie-Claude Couture; Kelsey Maher; Kimberly Page
Journal:  J Assoc Nurses AIDS Care       Date:  2012-11-17       Impact factor: 1.354

Review 4.  The intersecting risks of substance use and HIV risk among substance-using South African men and women.

Authors:  Felicia A Browne; Wendee M Wechsberg
Journal:  Curr Opin Psychiatry       Date:  2010-05       Impact factor: 4.741

5.  Latent class analysis of polysubstance use, sexual risk behaviors, and infectious disease among South African drug users.

Authors:  Rebecca C Trenz; Michael Scherer; Alexandra Duncan; Paul T Harrell; Anne Gloria Moleko; William W Latimer
Journal:  Drug Alcohol Depend       Date:  2013-04-03       Impact factor: 4.492

6.  Understanding the gender disparity in HIV infection across countries in sub-Saharan Africa: evidence from the Demographic and Health Surveys.

Authors:  Monica Akinyi Magadi
Journal:  Sociol Health Illn       Date:  2011-05

7.  Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.

Authors:  Hao Feng; Han Zhang; Jiusheng Deng; Li Wang; Yuan He; Shelly Wang; Roheila Seyedtabaei; Qing Wang; Laiting Liu; Jacques Galipeau; Richard W Compans; Bao-Zhong Wang
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

8.  Hidden populations: discovering the differences between the known and the unknown drug using populations in the Republic of Georgia.

Authors:  M Gogia; C Lawlor; N Shengelia; K Stvilia; H F Raymond
Journal:  Harm Reduct J       Date:  2019-02-12

Review 9.  Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection.

Authors:  Chongbo Zhao; Zhujun Ao; Xiaojian Yao
Journal:  Vaccines (Basel)       Date:  2016-01-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.